Literature DB >> 18357419

Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke.

Latha G Stead1, Rachel M Gilmore, M Fernanda Bellolio, Shaily Mishra, Anjali Bhagra, Lekshmi Vaidyanathan, Wyatt W Decker, Robert D Brown.   

Abstract

OBJECTIVE: To determine if differences in outcome exist between diabetic and non-diabetic patients who present to the Emergency Department (ED) with acute ischemic stoke (AIS) and elevated blood glucose.
METHODS: The study population consisted of 447 consecutive patients who presented to the ED with AIS within 24 h of symptom onset and had blood glucose measured on presentation. Hyperglycemia was defined as >130 mg/dl. Outcomes studied included infarct volume, stroke severity (NIH Stroke Scale), functional impairment (modified Rankin Score), and 90-day mortality. Patients with hyperglycemia were then stratified into those with and without a prior history of diabetes mellitus (DM) for the purposes of analysis.
RESULTS: Patients with hyperglycemia exhibited significantly greater stroke severity (P = 0.002) and greater functional impairment (P = 0.004) than those with normoglycemia. Patients with hyperglycemia were 2.3 times more likely to be dead at 90 days compared to those with normal glucose (P < 0.001). Stroke severity (P < 0.001) and functional impairment (P < 0.001) were both significantly worse in patients with hyperglycemia and no prior history of DM, when compared to patients with hyperglycemia and previously diagnosed DM. Among the patients without a prior history of DM, patients with hyperglycemia were 3.4 times more likely to die within 90 days (P < 0.001) when compared with patients with normoglycemia. In contrast, the hazard ratio was 1.6 among the patients with DM (P = 0.66).
CONCLUSION: Hyperglycemia on presentation is associated with significantly poorer outcomes following AIS. Patients with hyperglycemia and no prior history of DM have a particularly poor prognosis, worse than that for patients with known diabetes and hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18357419     DOI: 10.1007/s12028-008-9080-0

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  19 in total

Review 1.  Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; P Pathak; H C Gerstein
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

2.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

3.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

4.  Reliability and validity of estimating the NIH stroke scale score from medical records.

Authors:  S E Kasner; J A Chalela; J M Luciano; B L Cucchiara; E C Raps; M L McGarvey; M B Conroy; A R Localio
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

5.  Retrospective assessment of initial stroke severity with the NIH Stroke Scale.

Authors:  L S Williams; E Y Yilmaz; A M Lopez-Yunez
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

6.  Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation.

Authors:  J M Hoxworth; K Xu; Y Zhou; W D Lust; J C LaManna
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

7.  Prognosis after stroke in diabetic patients. A controlled prospective study.

Authors:  T Olsson; M Viitanen; K Asplund; S Eriksson; E Hägg
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

8.  Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations.

Authors:  B Lin; M D Ginsberg; R Busto
Journal:  Acta Neuropathol       Date:  1998-12       Impact factor: 17.088

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat.

Authors:  W A Pulsinelli; S Waldman; D Rawlinson; F Plum
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

View more
  39 in total

1.  Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage.

Authors:  Latha G Stead; Anunaya Jain; M Fernanda Bellolio; Adetolu Odufuye; Rachel M Gilmore; Alejandro Rabinstein; Raghav Chandra; Ravneet Dhillon; Veena Manivannan; Luis A Serrano; Neeraja Yerragondu; Balavani Palamari; Minal Jain; Wyatt W Decker
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 2.  A review of perioperative glucose control in the neurosurgical population.

Authors:  Joshua H Atkins; David S Smith
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 3.  Treating hyperglycemia in neurocritical patients: benefits and perils.

Authors:  Daniel A Godoy; Mario Di Napoli; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  Effect of hyperglycemia on brain penetrating arterioles and cerebral blood flow before and after ischemia/reperfusion.

Authors:  Marilyn J Cipolla; Julie A Godfrey
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

5.  SOD1 overexpression prevents acute hyperglycemia-induced cerebral myogenic dysfunction: relevance to contralateral hemisphere and stroke outcomes.

Authors:  Maha Coucha; Weiguo Li; Sherif Hafez; Mohammed Abdelsaid; Maribeth H Johnson; Susan C Fagan; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-31       Impact factor: 4.733

6.  Insulin-treated diabetes is not associated with increased mortality in critically ill patients.

Authors:  Jean-Louis Vincent; Jean-Charles Preiser; Charles L Sprung; Rui Moreno; Yasser Sakr
Journal:  Crit Care       Date:  2010-02-04       Impact factor: 9.097

Review 7.  Glycemic variability and acute ischemic stroke: the missing link?

Authors:  Emmanuel I González-Moreno; Carlos R Cámara-Lemarroy; José G González-González; Fernando Góngora-Rivera
Journal:  Transl Stroke Res       Date:  2014-08-03       Impact factor: 6.829

8.  Hyperglycemia is associated with more severe cytotoxic injury after stroke.

Authors:  Matthew B Bevers; Neil H Vaishnav; Ly Pham; Thomas Wk Battey; W Taylor Kimberly
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 9.  Antidiabetic treatment, stroke severity and outcome.

Authors:  Dimitra Magkou; Konstantinos Tziomalos
Journal:  World J Diabetes       Date:  2014-04-15

10.  Aggressive glucose control for acute ischemic stroke patients by insulin infusion.

Authors:  Nayoung Kim; Yunsook Jhang; Jong-Moo Park; Byung-Kun Kim; Ohyun Kwon; Jungju Lee; Ji-Sung Lee; Ja-Seong Koo
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.